Document is current
Any future updates will be listed below
-
Authors
Kling, Agnes
Kusche-Palenga, Julia
Palleis, Carla
Jäck, Alexander
Bernhardt, Alexander M.
Frontzkowski, Lukas
Roemer, Sebastian N.
Slemann, Luna
Zaganjori, Mirlind
Scheifele, Maximilian
Paeger, Lars
Bischof, Gérard N.
van Eimeren, Thilo
Drzezga, Alexander
Sabri, Osama
Rullmann, Michael
Barthel, Henryk
Levin, Johannes
Herms, Jochen
Franzmeier, Nicolai
Höglinger, Günter
Roeber, Sigrun
Brendel, Matthias
Gnörich, Johannes https://orcid.org/0000-0003-1554-7765
-
Funding
Funding for this research was provided by:
Klinikum der Universität München
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 6 March 2025
First Online: 18 March 2025
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (LMU Munich, application number 17–569) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: All participants provided written informed consent prior to the PET scan.
: The authors affirm that human research participants provided informed consent for publication of the images in all Figures.
: AD reports: research support: Siemens Healthineers, Life Molecular Imaging, GE Healthcare, AVID Radiopharmaceuticals, Sofie, Eisai, Novartis/AAA, Ariceum Therapeutics; Speaker Honorary/Advisory Boards: Siemens Healthineers, Sanofi, GE Healthcare, Biogen, Novo Nordisk, Invicro, Novartis/AAA, Bayer Vital, Lilly, Peer View Institute for Medical Education, International Atomic Energy Agency: Stock: Siemens Healthineers, Lantheus Holding, Structured therapeutics, Lilly; Patents: Patent for 18F-JK-PSMA- 7 (Patent No.: EP3765097A1; Date of patent: Jan. 20, 2021). MB received speaker honoraria from Roche, Iba, GE healthcare and Life Molecular Imaging, is an active advisor of MIAC, and advised GE Healthcare Life Molecular Imaging.
